Abstract-Hypertension is one of the major risk factors for chronic kidney disease. Using quantitative trait loci analysis, we identified the gene of the F-BAR protein NOSTRIN in the center of an overlapping region in rat and human quantitative trait loci that are associated with hypertension. Immunohistochemical analysis revealed a predominantly podocytic expression pattern of NOSTRIN in human and mouse glomeruli. Further, NOSTRIN colocalizes with cell-cell contactassociated proteins β-catenin and zonula occludens-1 and interacts with the slit-membrane-associated adaptor protein CD2AP. In zebrafish larvae, knockdown of nostrin alters the glomerular filtration barrier function, inducing proteinuria and leading to ultrastructural morphological changes on the endothelial and epithelial side and of the glomerular basement membrane of the glomerular capillary loop. We conclude that NOSTRIN expression is an important factor for the integrity of the glomerular filtration barrier. Disease-related alteration of NOSTRIN expression may not only affect the vascular endothelium and, therefore, contribute to endothelial cell dysfunction but might also contribute to the development of podocyte disease and proteinuria. 
H ypertension belongs to the most severe health issues worldwide, and persistent hypertension is one of the leading causes of chronic kidney disease. Because the pathogenesis of hypertension is complex and multifactorial, deciphering the underlying mechanisms is a complex struggle. The establishment of specific mouse and rat strains with genetically determined hypertension as well as extensive genetic screens in humans allowed for narrowing the search for possible candidate genes. 1, 2 Using a cross between Dahl salt-sensitive and Lewis rats, Garrett et al 3 were able to link a chromosomal region on chromosome 3 with differences in blood pressure. This analysis was confirmed and refined using congenic lines originating from these same strains. 4 Overlapping quantitative trait loci were later found for blood pressure in a cross between Dahl salt-sensitive and Brown Norway rats 5 and for kidney mass (a blood pressure-related trait) in a cross between Lyon hypertensive and Lyon normotensive rats. 6 Moreover, linkage between premature hypertension and a region on chromosome 2 was shown in a human family in Kyrgyzstan. 7 This region is, in part, orthologous to the rat chromosome 3. The common overlapping region of 7.6 Mb was defined by the 2 markers D3Chm63 and D3Rat180. There are 88 annotated genes within this region (Ensembl Rnor_5.0), including NOSTRIN. The linkage data relative to rat chromosome 3 are summarized in Figure S1 in the online-only Data Supplement.
NOSTRIN was originally described by Zimmermann et al 8 as an F-BAR domain-containing protein involved in shuttling of endothelial NO synthase. Recently, the same group demonstrated that knocking down NOSTRIN in zebrafish resulted in impaired vasculogenesis and, probably by impaired fibroblast growth factor (FGF) signaling, NOSTRIN-deficient mice develop disordered vascular patterning in the postnatal retina. 9 We showed that distribution of tight junctions in the blood-brain barrier capillaries of stroke-prone spontaneously hypertensive rats was altered, and that this finding was accompanied by changes in the transcript level of NOSTRIN. 10 These data demonstrate that NOSTRIN might carry far more cellular functions beyond NO signaling. We here report on the role of NOSTRIN in the kidney with a special emphasis on the glomerular expression of NOSTRIN.
Results

NOSTRIN Is Expressed in Glomerular Podocytes
Immunostainings with a polyclonal antibody directed against a peptide localized near the C terminus of rodent NOSTRIN revealed that NOSTRIN is expressed in peritubular capillaries and glomerular structures ( Figure 1A ). Double stainings with podocytic and endothelial markers showed that glomerular NOSTRIN expression could be assigned to podocytic structures ( Figure 1B) . A strong colocalization of NOSTRIN and the endothelial cell marker thrombomodulin could be observed in vascular structures outside the glomerulus (data not shown). Immunostainings of human kidney sections with an antibody directed against human NOSTRIN confirmed podocytic distribution pattern in the glomerulus ( Figure 1C ).
NOSTRIN Interacts With Cell Contact-Associated Proteins in Human Podocytes
To further characterize NOSTRIN expression in podocytes, we performed double stainings of NOSTRIN with the cell contact-associated proteins β-catenin and zonula occludens-1 in cultured human podocytes. As depicted in Figure 2A , NOSTRIN displayed a close colocalization with β-catenin and zonula occludens-1 in regions of cell-cell contacts (Figure 2A) . Coimmunoprecipitation experiments demonstrated that NOSTRIN interacts with cell-cell contact-specific proteins β-catenin, CD2AP, and caveolin-1 ( Figure 2B ).
Knockdown of NOSTRIN Induces a Renal Phenotype in Zebrafish
To prove that NOSTRIN is relevant for the integrity of the glomerular filtration barrier, we analyzed functional effects of NOSTRIN loss on the kidney in vivo in larval zebrafish. Although rat or human NOSTRIN is only 44% homologous to their zebrafish equivalent, the different functional domains remain conserved between the different species indicating that the zebrafish NOSTRIN orthologue might have similar functions ( Figure 3A) . After injection of 100 to 250 μmol/L nostrin-specific morpholinos, zebrafish embryos developed an edematous phenotype as depicted in Figure 3B . This phenotype includes a general edema of the body with accentuated pericardial effusion, yolk sac edema, and an arched back. The cardiovascular system seemed to develop normally. Embryos were less active in their movement and less likely to hatch spontaneously. In contrast, embryos that were injected with control morpholino at equivalent concentrations did not develop a phenotype and showed normal hatching rates.
Nostrin Knockdown in Zebrafish Leads to Proteinuria
To visualize the glomerular loss of high molecular weight proteins, we used a wt1b-GFP transgenic zebrafish 11 that expresses green fluorescence in the fused glomeruli and in the proximal tubules of the pronephros. In NOSTRIN knockdown fish, a 70-kDa rhodamine-labeled dextran was injected at 72 hours post fertilization into the cardinal vein. Forty-eight hours post injection, the extravasation of rhodamine-labeled dextran could be detected within the wt1b-GFP-tagged proximal tubular cells of the morphants ( Figure 4A ) indicating leakage of the high molecular weight dextran through the filtration barrier and reuptake in the proximal tubular cells.
To further analyze and to quantify the proteinuria, we measured loss of fluorescence in the vasculature using a transgenic zebrafish line Tg(l-fabp:DBP-eGFP) expressing a GFP-tagged vitamin D binding protein (DBP) with a molecular weight of 78 kDa under the control of the l-fabp (liver-type fatty acid binding protein promotor). Injection of nostrin morpholinos resulted in a significant loss of fluorescence activity in the retinal blood vessels of morphants 96 hours post fertilization to 144 hours post fertilization, whereas fluorescence activity remained stable or even increased in control morpholino-injected larvae ( Figure 4B ). These results could be confirmed by dot-blot analysis of secreted DBP-enhanced green fluorescent protein ( Figure 4C ).
Knockdown of NOSTRIN Affects Glomerular Ultrastructure
To determine the structural integrity of the filtration barrier in the nostrin morphant fish, we analyzed glomeruli of 120 hours postfertilization embryos by transmission electron microscopy ( Figure 5 ). In contrast to the normal glomerular ultrastructure of control-injected fish ( Figure 5A ), we detected severe ultrastructural changes in the podocyte structure with effacement of the podocyte foot processes and swelling of the endothelium in the morpholino-injected fish ( Figure 5B and 5C). In addition, we found severe alterations of the basement membrane that appeared thickened and in some areas even split and disrupted. These functional and ultrastructural data demonstrate a disturbed barrier function of the zebrafish pronephros after knockdown of nostrin.
Discussion
Patients with nondiabetic chronic kidney disease (as defined with an estimated glomerular filtration rate (eGFR) of <60 mL/min per 1.73 m 2 or proteinuria) and coexistent hypertension have an increased risk of cardiovascular events and death. 12 In turn, coexistent hypertension is responsible for the progression of chronic kidney disease with accelerated segmental or global glomerulosclerosis that may be superimposed on the phenotype of the underlying kidney disease. 13, 14 In this context, identification of genes and gene products that are linked to structural changes of the kidney remains one of the key questions in the analysis of renal impairment during hypertension. Analysis of overlapping quantitative trait loci represents a powerful tool to narrow down the endless list of potential candidate genes in the development of hypertension and cardiovascular disease. Applying quantitative trait loci analyses, we identified NOSTRIN within the overlapping regions linked to blood pressure-related traits in rats and in a kyrgyz family, suggesting a mechanistic role for NOSTRIN in hypertension-associated end organ failure.
NOSTRIN consists of an N-terminal F-BAR domain and a C-terminal SH3 domain that mediate plasma membrane binding and protein-protein interactions. 15 It has been attributed to the control of endothelial nitric oxide synthase activity and has been shown to interact with dynamin-2, neural WiskottAldrich syndrome protein, and caveolin-1. 15, 16 More recently, the same group showed that NOSTRIN is involved in vascular development and that loss of NOSTRIN resulted in impaired vascular patterning. 9 Here, we showed that in human and rodent glomeruli, NOSTRIN is expressed predominantly in epithelial podocytes and interacts with proteins such as CD2AP that are known to be essential for proper slit-membrane function. In mice, inhibition of neural Wiskott-Aldrich syndrome protein by c-mip (c-maf-inducing protein) induces heavy proteinuria and accounts for cytoskeletal disorganization and effacement of foot processes in podocytes. 17 Similar pathological mechanisms, for example, reorganization of the podocytic cytoskeleton and proteinuria, have also been described for cleavage of dynamin by cathepsin-L, and overexpression of mutant dynamin that is resistant to cathepsin-L cleavage circumvented proteinuria and foot process retraction. 18 As both proteins represent potential interaction partners of NOSTRIN, it is conceivable that NOSTRIN functions as an adaptor molecule controlling correct spatial localization of dynamin and neural Wiskott-Aldrich syndrome protein and, therefore, modulates podocyte architecture. However, NOSTRIN is described to interact with fibroblast growth factor-1 receptor (FGFR1) and the small G-protein Rac1. 9 Rac1 is known to modulate cell adhesion and migration through cytoskeletal reorganization processes. More recently, a study demonstrated that Rac1 is necessary for recruitment of the adaptor protein CD2AP to regions of cell-cell contacts where it modulates proper junction formation in epithelial cells. 19 These data propose a model, in which NOSTRIN, Rac1, and CD2AP form a complex that modulates correct formation of the glomerular slit membrane.
Further evidence for a role of NOSTRIN in proper function of the podocytic filtration unit came from the zebrafish knockdown experiments where we could demonstrate that NOSTRIN deficiency results in a severe edematous phenotype that is associated with enhanced clearance of serum proteins, functional renal impairment, and loss of size selectivity of the glomerular filter. At the ultrastructural level, nostrin knockdown induced podocyte foot process effacement, swelling of glomerular endothelial cells, and, in more severe phenotypes, damage of the glomerular basement membrane. Whether the primary insult could be assigned to the podocytes or to both podocytes and endothelial cells will be subject of further examinations.
Perspective
We here demonstrated that NOSTRIN might evolve as a key player of mechanisms of proteinuria in hypertensive kidney disease. Further studies on regulation and function of NOSTRIN expression in the kidney and identification of possible interaction partners in podocytes are in progress in our laboratory and might pave the way for a possible novel mechanism in the development of proteinuria in cardiovascular disease.
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